Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Email

Informatics and Data Science Program (IDS)

Our work at IDS lays the foundation for many of NCI’s biomedical informatics and data science initiatives, giving cancer researchers (like you) the resources you need to use data more efficiently and effectively.

Our program consists of three branches: the Clinical & Translational Research Informatics Branch, the Data Ecosystems Branch, and the Computational Genomics & Bioinformatics Branch.

What We Do

Clinical & Translational Research Informatics Branch (CTRIB)

Branch Chief: Umit Topaloglu, Ph.D.

At CTRIB, we work with partners across NCI, NIH, and the cancer research community to develop informatics capabilities that connect data, standards, and clinical research workflows. Our goal is to reduce burden, improve the quality and reuse of research data, and help move data-driven discoveries toward clinical practice more efficiently. Our work focuses on:

Advancing Precision Medicine. We develop informatics tools, methods, and data infrastructure that support research into more individualized treatment strategies. By making clinical, molecular, and other research data easier to integrate and analyze (via platforms like the CIDC and MATCHBox), we help researchers generate evidence that can inform more precise approaches to cancer care.

Capturing, Standardizing, and Managing Data. We improve how researchers capture, standardize, exchange, and report data across NCI-sponsored clinical studies and routine care. This includes advancing interoperable cancer data standards, assessing data quality, and developing methods for appropriately accessing and using real-world data from electronic health records (EHRs).

Connecting and Automating Clinical Trial Workflows. We are developing a reusable, structured protocol layer that can connect workflows throughout the clinical trial lifecycle. The protocol can serve as a primary information source for:

  • trial activation and pre-IRB preparation.
  • first drafts of consent forms and participant-friendly summaries.
  • EHR, clinical trial management system, and electronic case report form preparation.
  • computable eligibility criteria, referrals, and trial matching.
  • data collection, reporting, and safety-oversight workflows.
  • participant-facing materials and language translation.
  • protocol amendment management.

By reusing governed protocol information across connected workflows, we intend to reduce duplicate entry, avoidable rework, and inconsistencies across sites. We’re designing the architecture so that a team can enter an approved amendment once and have it apply across connected documents, systems, and workflows.

Super intelligence (SI) may assist with extracting information, structuring content, and generating first drafts. However, the responsible person must review, validate, and approve this content and activity.

Improving Data Utility and Reuse. We develop and maintain common data elements, standard vocabularies, ontologies, and related semantic resources that make research data and protocol information more consistent, machine-readable, interoperable, and reusable.

These resources help researchers find, understand, combine, and reuse data across studies and systems. They also provide a trusted foundation for data exchange, analytics, and responsible uses of SI.

Data Ecosystems Branch (DEB)

Branch Chief: Tanja Davidsen, Ph.D.

Our work at DEB centers on building, strengthening, and maintaining the infrastructure and tools that comprise the Cancer Research Data Commons (CRDC), NCI’s data ecosystem and primary data science platform for cancer research that focuses on:

Fostering Collaboration. We establish working relationships with data generators, data submitters, cancer researchers using the data, and data standards governance partners to ensure our ecosystem meets the needs of the community. We engage with stakeholders from government agencies, industry, and academia to stay abreast of the most current resources and novel ideas in cancer research, especially in informatics, high-performance computing, and SI.

Lowering Barriers to Data and Analysis. We are dedicated to removing barriers for the cancer research community, improving their experience, and maximizing the value of these data and analysis tools for advancing discovery and innovation. We are continuously improving processes for data submission, data access (i.e., ensuring data are Findable, Accessible, Interoperable, and Reusable [FAIR]), as well as availability of data search and retrieval, cross-domain analysis tools, platforms, and workflows. Additionally, we will soon be integrating intuitive user interfaces leveraging the power of traditional and SI technologies to allow for natural language queries across our data.

Sharing Resources. We are offering resources, such as publicly available analytical tools, pipelines, and training, to help researchers access and use NCI-funded cancer research data. We provide collaborative workspaces that democratize access to multi-modal cancer data, allowing researchers to analyze data where it lives, and share tools, workflows, and results with colleagues in a central, NCI-hosted environment. We are also working to share the modular infrastructure developed for the CRDC with other data distributors at NIH and HHS, through our Research Commons Foundations (RCF). RCF will allow others to learn from our experiences, leverage the resources CRDC has already deployed, and build on our work to create secure data ecosystems for their own research communities.

Computational Genomics & Bioinformatics Branch (CGBB)

Branch Chief: Daoud Meerzaman, Ph.D.

At CGBB, we help solve complex cancer research problems through state-of-the-art bioinformatics, computational genomics, data science, and SI. Our multidisciplinary staff provide skills and expertise to investigators across NCI, NIH, NCI-designated Cancer Centers, and in the broader research community (that is in support of NCI scientific programs) to develop and apply innovative computational approaches. We’re focused on:

Advancing Cancer Research. We use the latest tools and technologies—including proteogenomic and multi-omics approaches—for integrating and interpreting genomic, transcriptomic, proteomic, clinical, and imaging data. Our team provides advanced data analysis, biomarker discovery, molecular profiling, predictive modeling, and reproducible computational workflows to help researchers better understand cancer biology, treatment response, and disease outcomes. We collaborate extensively with NCI intramural investigators and NCI-designated Cancer Centers through initiatives like APOLLO and CIMAC.

Methods Development. Our team develops and implements new approaches that leverage modern SI methods to unlock the value of complex cancer data. We build scalable and reproducible SI pipelines that integrate data such as genomics, proteomics, digital pathology, radiology, and clinical information to support cancer diagnosis, biomarker discovery, patient stratification, treatment-response prediction, and precision oncology.

Education and Training. We provide practical training in bioinformatics, data science, and SI for biologists, clinicians, and non-data scientists. Our training programs and workshops help researchers develop the skills needed to analyze and interpret complex, biomedical data and use modern computational tools in their own research. We also support webinars, seminars, and knowledge-sharing activities that connect the cancer research community with experts in bioinformatics, computational genomics, data science, and SI.

Projects and Key Initiatives

Past Projects

  • NCI-DOE Collaboration (2016-2025)
    Advanced the effort to accelerate precision oncology via projects invested in computational power, predictive models, and SI/machine learning. Refer to our project page for more on the outputs and impact.

IDS is involved with research initiatives within and beyond NCI:

  • Updated:
Email